CoreCap Advisors’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.9K Sell
662
-10
-1% -$604 ﹤0.01% 1492
2026
Q1
$39.3K Hold
672
﹤0.01% 1408
2025
Q4
$38K Buy
672
+64
+11% +$3.49K ﹤0.01% 1429
2025
Q3
$32.3K Hold
608
﹤0.01% 1484
2025
Q2
$28.8K Sell
608
-190
-24% -$8.41K ﹤0.01% 1474
2025
Q1
$33K Sell
798
-1,724
-68% -$67.8K ﹤0.01% 1343
2024
Q4
$91.6K Hold
2,522
﹤0.01% 958
2024
Q3
$92.3K Buy
+2,522
New +$90.1K ﹤0.01% 948
2024
Q2
Sell
-2,370
Closed -$72.3K 1736
2024
Q1
$72.3K Buy
+2,370
New +$71.3K ﹤0.01% 974
2022
Q4
$94.8K Buy
+2,370
New +$93.1K 0.01% 757
2022
Q3
Sell
-107
Closed -$5K 736
2022
Q2
$5K Buy
+107
New +$4.59K ﹤0.01% 1662
2022
Q1
Sell
-108
Closed -$4K 747
2021
Q4
$4K Buy
+108
New +$3.83K ﹤0.01% 1784

Other funds holding BTI

CoreCap Advisors's BTI Position: Q2 2026 in Review

CoreCap Advisors reduced its British American Tobacco (BTI) stake by 1.5% in Q2 2026, selling an estimated $604 and leaving 662 shares worth $40.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1492.

CoreCap Advisors first reported a position in BTI in Q4 2021 and has held it in 12 quarters since. The position peaked at $94.8K in Q4 2022. 907 funds tracked by Wall St. Rank hold BTI as of Q2 2026.

  • CoreCap Advisors held 662 shares of British American Tobacco worth $40.9K as of Q2 2026.
  • CoreCap Advisors sold 10 British American Tobacco shares in Q2 2026, an estimated $604.
  • British American Tobacco made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1492 holding.
  • CoreCap Advisors first reported a position in British American Tobacco in Q4 2021 and has held it in 12 quarters since.
  • CoreCap Advisors's British American Tobacco position peaked at $94.8K in Q4 2022.
  • 907 funds tracked by Wall St. Rank held British American Tobacco as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.